MCTANasdaqServices-Misc Health & Allied Services, NEC
Charming Medical Ltd
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 30, 2026
$29.36+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$21.95 (+296.2%)since Oct 24, 2025
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.
Charming Medical Ltd saw revenue fall 22.7% to $4.81M over fiscal 2026. Operating income fell 102.1% to -$29.24K, moving the operating margin from 22.3% to -0.6%. Free cash flow was -$1.56M, down 1224.2% from a year earlier.
Revenue
$4.81M
-22.7% vs. a year earlier
Operating income
-$29.24K
-102.1% vs. a year earlier
Free cash flow
-$1.56M
-1224.2% vs. a year earlier
EPS, diluted
$0.00
-100.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Mar 31, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $4.81M
- Net income
- -$22.65K
- EPS, diluted
- $0.00
- Free cash flow
- -$1.56M
Four years at a glance
Fiscal years 2023 to 2026, USD
Revenue
$4.81M-22.7% YoY
Gross profit
$4.77M-23.1% YoY
Operating income
-$29.24K-102.1% YoY
Net income
-$22.65K-101.9% YoY
EPS, diluted
$0.00-100.0% YoY
Free cash flow
-$1.56M-1224.2% YoY
Reported period